vaccines

BioNTech to Receive $120 Million Upfront Payment from Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
BioNTech to Receive $120 Million Upfront Payment from Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
CP Wire
BioNTech
Pfizer
flu vaccines
vaccines
Flag link:
Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead
Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead
Fierce Pharma
Merck
Gardasil
vaccines
HPV
Flag link:
U.K. to offer Merck's Gardasil to boys after years of protests
U.K. to offer Merck's Gardasil to boys after years of protests
Fierce Pharma
UK
Merck
Gardasil
HPV
vaccines
Flag link:
Chance for global vaccine makers? China’s latest vaccine scandal sparks fury and fear
Chance for global vaccine makers? China’s latest vaccine scandal sparks fury and fear
Fierce Pharma
China
vaccines
Flag link:
Vaccine maker PaxVax tackles the unmet need posed by chikungunya virus
Vaccine maker PaxVax tackles the unmet need posed by chikungunya virus
Drug Delivery Business News
vaccines
PaxVax
chikungunya virus
mosquito-borne disease
Flag link:
Senators demand more from GlaxoSmithKline to boost Shingrix supply
Senators demand more from GlaxoSmithKline to boost Shingrix supply
Fierce Pharma
GSK
vaccines
Shingrix
shingles
Senate
Flag link:
SIGA Technologies Publishes Positive Data For Its Oral Small Pox Vaccine
SIGA Technologies Publishes Positive Data For Its Oral Small Pox Vaccine
CP Wire
SIGA technologies
vaccines
smallpox
TPOXX
Flag link:
Big Pharma Rises To The Ebola Challenge
Big Pharma Rises To The Ebola Challenge
Forbes
ebola virus
vaccines
Flag link:
Comparing vaccine incentives in the US and Europe
Comparing vaccine incentives in the US and Europe
Biopharma Dive
vaccines
drug development
United State
Europe
Flag link:
Immunotherapy advances spur new look at cancer vaccines
Immunotherapy advances spur new look at cancer vaccines
Biopharma Dive
cancer immunotherapy
cancer vaccines
vaccines
Flag link:
HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women
HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women
Xtalks
vaccines
HPV
cervical cancer
Gardasil
Merck
Denmark
Flag link:
GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand
GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand
Fierce Pharma
GSK
Shingrix
shingles
vaccines
Flag link:
Controversial researcher’s diabetes vaccine causes improvement in small study
Controversial researcher’s diabetes vaccine causes improvement in small study
Stat
type 1 diabetes
diabetes
clinical trials
insulin
vaccines
Organon Teknika
Flag link:
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
CP Wire
OncBioMune
ProscaVax
prostate cancer
vaccines
clinical trials
Flag link:
Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO
Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO
Fierce Pharma
Imutex
FLU-v
vaccines
universal flu vaccine
flu vaccines
Flag link:
Study confirms higher risk of dengue in kids who got Sanofi vaccine
Study confirms higher risk of dengue in kids who got Sanofi vaccine
Reuters
Sanofi
dengue
vaccines
Flag link:
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
Fierce Pharma
GSK
Merck
Sanofi
Pfizer
Novavax
vaccines
Flag link:
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
Xconomy
MRNA
Sanofi
Translate Bio
vaccines
R&D
Flag link:
More bad news for Vical as it abandons herpes vaccine program
More bad news for Vical as it abandons herpes vaccine program
Fierce Biotech
Vical
vaccines
herpes simplex vaccine
VCL-HB01
Flag link:
Advaxis cuts staff as it seeks partner for troubled cancer vaccine
Advaxis cuts staff as it seeks partner for troubled cancer vaccine
Fierce Biotech
Advaxis
layoffs
vaccines
axalimogene filolisbac
cancer vaccines
immunotherapy
Flag link:

Pages